TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Pear Therapeutics Stock

Pear Therapeutics Stock

peartherapeutics.comHealthcareFounded: 2013Funding to Date: $139MM

Pear discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.

Learn more about Pear Therapeutics IPO
Register for Details

For more details on financing and valuation for Pear Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pear Therapeutics.

Register Today

Team

Management Team

Alex Waldron
Chief Commercial Officer
Stephen Smith JD
Co-Founder & Executive Vice President of Corporate Development
Walter Greenleaf Ph.D
Chief Science Advisor
Christopher Guiffre JD
Chief Operating Officer & Chief Financial Officer
Yuri Maricich MD
Chief Medical Officer & Head of Clinical Development
Jeffrey Lieberman
Advisor
Corey McCann Ph.D
Co-Founder, President, Chief Executive Officer & Board Member
Jeremy Gilbert
Chief Product Officer
Beth Rogozinski
Chief Content Advisor

Board Members

Andrew Schwab
5AM Ventures
John Harris
JAZZ Venture Partners
Zack Lynch
JAZZ Venture Partners
Corey McCann Ph.D
Jeremy Sohn
Timothy Petersen
Arboretum Ventures
Delaine Cheong
Temasek Holdings
Jamil Beg
5AM Ventures
Thomas Shehab MD
Arboretum Ventures
Hu Hongjie
Temasek Holdings

Other companies like Pear Therapeutics in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Paradromics
Sector
Healthcare
 
 
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
OURA
Sector
Healthcare
 
 
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM

News

Mobi Health News 01/07/2019
Pear Therapeutics rakes in $64M for reSET commercialization, product development
The latest funding was led by Temasek, with participation from Novartis, 5AM Ventures, Arboretum Ventures, Jazz Partners, The Bridge Builders Collaborative and EDBI.

Trending Companies

Frequently Asked Questions

Updated on: Jun 8, 2023